Heart Monitoring Device After Acute Myocardium Infarction
Monitor
1 other identifier
interventional
358
0 countries
N/A
Brief Summary
Verify the effectiveness of a Heart Monitor in preventing events in patients over 18 years after acute myocardial infarction in a clinical unit. Patients with neurological disease or congenital heart disease we excluded from the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2019
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 22, 2018
CompletedFirst Posted
Study publicly available on registry
April 11, 2018
CompletedStudy Start
First participant enrolled
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2020
CompletedApril 8, 2019
April 1, 2018
4 months
January 22, 2018
April 4, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Heart rhythm monitoring
Evaluating the effectiveness of a heart monitoring device in the prevention and detection of events in patients after acute myocardial infarction
One year
Study Arms (2)
Heart Monitor
EXPERIMENTALWe used the device (heart monitor) in the patients with myocardial infarction.
No Heart Monitor
ACTIVE COMPARATORNo heart monitor device in the patients with myocardial infarction (control).
Interventions
Use of heart monitor device in the patients after acute myocardium infarct.
Standard monitoring by nurses.
Eligibility Criteria
You may qualify if:
- patients over 18 years
- patients post-acute myocardial infarctium
You may not qualify if:
- patients with neurological disease
- patients with congenital heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
silvia goldmeier
Instituto de Cardiologia do Rio Grande do Sul
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 22, 2018
First Posted
April 11, 2018
Study Start
May 1, 2019
Primary Completion
September 1, 2019
Study Completion
July 1, 2020
Last Updated
April 8, 2019
Record last verified: 2018-04